 Arcadia Biosciences Inc NASDAQ:RKDA FRA:17D posted fourth-quarter results on Wednesday that saw its revenue rocket nearly 1,606 year-over-year on the back of demand for its new wheat and hemp products and several strategic transactions with Bioceres Crop Solutions NYSEAMERICAN:BIOX. For the period ended December 31, 2020, the Davis, California-based company reported revenue of 7.1 million, compared to 416,000 in the fourth quarter of 2019. 